Recent News

May 29, 2015 – Clear-Cut Medical, the Rehovot, Israel based company, has completed a Series B financing to support its continued product development and commercialization of its novel ClearSightTM MRI system for cancer surgery margin assessment, where first clinical trials are being conducted for breast conserving surgery. The financing was led by Previz Ventures. The…

ClearCut Medical was featured in today’s issue of Medtech Strategist, in a “Start-up to Watch” piece by Mary Stuart titled: “ClearCut Medical, accurate tumor margin assessment in the OR”. The 2-page story includes an interview with CEO Eyal Kolka and VP Sales and Marketing, Scott Peairs.